Maher Albitar serves as Executive at NEOGENOMICS INC, where they oversee executive responsibilities. Since joining the company, Maher Albitar has executed 11 insider transactions totaling $4.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 23, 2016 involved selling 2,800 shares valued at $23.5K.
Maher Albitar currently holds 60,692 shares of NEOGENOMICS INC (NEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maher Albitar has been a net seller of NEO stock. They have purchased $50.9K and sold $4.4M worth of shares.
Maher Albitar's most recent insider trade was on Sep 23, 2016, when they sold 2,800 shares at $8.40 per share.
Get notified when new Form 4 filings are submitted
| $8.20 |
| Discretionary |
| Sep 12, 2016 | NEO | $418.7K | Sale | 51,000 | $8.21 | Discretionary |
| Sep 9, 2016 | NEO | $75.4K | Sale | 9,075 | $8.31 | Discretionary |
| Aug 19, 2016 | NEO | $478.0K | Option Exercise | 100,000 | $4.78 | Discretionary |
| Aug 19, 2016 | NEO | $286.0K | Option Exercise | 200,000 | $1.43 | Discretionary |
| Aug 19, 2016 | NEO | $3.0M | Sale | 370,000 | $8.23 | Discretionary |
| Aug 19, 2016 | NEO | $357.5K | Option Exercise | 250,000 | $1.43 | Discretionary |
| Aug 19, 2016 | NEO | $286.0K | Payment | 34,625 | $8.26 | Discretionary |
| Aug 19, 2016 | NEO | $69.0K | Option Exercise | 20,000 | $3.45 | Discretionary |
| Mar 28, 2014 | NEO | $50.9K | Purchase | 14,492 | $3.51 | Discretionary |